The Economic Burden of Irritable Bowel Syndrome in Canada
In the treatment of irritable bowel syndrome (IBS), medical practitioners and policymakers face the task of providing both high quality and cost effective medical care for a condition with no certain cure. To date, studies have examined only total medical costs to patients with symptoms consistent w...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1999/569613 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | In the treatment
of irritable bowel syndrome (IBS), medical practitioners and
policymakers face the task of providing both high quality and cost
effective medical care for a condition with no certain cure. To
date, studies have examined only total medical costs to patients
with symptoms consistent with an IBS diagnosis. However, these
studies have not examined the direct and indirect costs incurred in
the course of treatment for IBS, excluding the costs of unrelated
medical conditions. Because patients with IBS have been shown
to differ significantly from non-IBS patients in their desire to seek
medical care, one cannot consider solely the cost differential in
medical costs for IBS and non-IBS patients. The present study examines
a set of patients who have been diagnosed with IBS and
seek medical care for IBS. |
|---|---|
| ISSN: | 0835-7900 |